These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 28383427)
1. Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome. Li M; Wang H; Xuan L; Shi X; Zhou T; Zhang N; Huang Y Medicine (Baltimore); 2017 Apr; 96(14):e6553. PubMed ID: 28383427 [TBL] [Abstract][Full Text] [Related]
2. Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance. Siasos G; Oikonomou E; Vavuranakis M; Kokkou E; Mourouzis K; Tsalamandris S; Zaromitidou M; Kioufis S; Tsigkou V; Deftereos S; Stefanadis C; Tousoulis D Cardiology; 2017; 137(2):104-113. PubMed ID: 28329746 [TBL] [Abstract][Full Text] [Related]
3. Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Aradi D; Komócsi A; Vorobcsuk A; Serebruany VL Thromb Haemost; 2013 Jan; 109(1):93-101. PubMed ID: 23197191 [TBL] [Abstract][Full Text] [Related]
4. Correlation P2Y12 Genetic Polymorphism As Risk Factor of Clopidogrel Resistance in Indonesian Stroke Patients. Hidayat R; Rasyid A; Harris S; Harahap A; Herqutanto ; Louisa M; Listiyaningsih E; Rambe AS; Loho T Vasc Health Risk Manag; 2023; 19():53-61. PubMed ID: 36743859 [TBL] [Abstract][Full Text] [Related]
5. [Association between clopidogrel resistance and polymorphism of platelet adenosine diphosphate receptor in patients with coronary atherosclerotic disease]. Li XJ; Chen XM Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 May; 43(3):333-8. PubMed ID: 24998658 [TBL] [Abstract][Full Text] [Related]
6. The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation. Liang ZY; Han YL; Zhang XL; Li Y; Yan CH; Kang J EuroIntervention; 2013 Jul; 9(3):316-27. PubMed ID: 23872648 [TBL] [Abstract][Full Text] [Related]
7. The impact of CYP3A5*1/*3, PIA1/A2 and T744C polymorphisms on clopidogrel and acetylsalicylic acid response variability in Mexican population. Isordia-Salas I; Olalde-Román MJ; Santiago-Germán D; de la Peña NC; Valencia-Sánchez JS Thromb Res; 2012 Sep; 130(3):e67-72. PubMed ID: 22819265 [TBL] [Abstract][Full Text] [Related]
8. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms. Kar R; Meena A; Yadav BK; Yadav R; Kar SS; Saxena R Platelets; 2013; 24(4):297-302. PubMed ID: 22721490 [TBL] [Abstract][Full Text] [Related]
10. [Resistance to clopidogrel and polymorphism of P2RY12 and GPIIIA genes in patients with chronic coronary heart disease]. Rebrova TIu; Muslimova EF; Afanas'ev SA; Sergienko TN; Repin AN Klin Med (Mosk); 2013; 91(8):29-31. PubMed ID: 24437181 [TBL] [Abstract][Full Text] [Related]
11. microRNA-605 rs2043556 polymorphisms affect clopidogrel therapy through modulation of CYP2B6 and P2RY12 in acute coronary syndrome patients. Zhou WL; Mo ZZ; Xiao FY; Dai W; Wang G; Zhou G; Zhang W; Chen BL Platelets; 2020 Oct; 31(7):897-905. PubMed ID: 31766967 [TBL] [Abstract][Full Text] [Related]
12. Effects of coexisting polymorphisms of CYP2C19 and P2Y12 on clopidogrel responsiveness and clinical outcome in patients with acute coronary syndromes undergoing stent-based coronary intervention. Tang XF; Zhang JH; Wang J; Han YL; Xu B; Qiao SB; Wu YJ; Chen J; Wu Y; Chen JL; Gao RL; Yang YJ; Yuan JQ Chin Med J (Engl); 2013 Mar; 126(6):1069-75. PubMed ID: 23506580 [TBL] [Abstract][Full Text] [Related]
13. Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: post-hoc analysis of the randomized PRASFIT-ACS study. Nakamura M; Isshiki T; Kimura T; Ogawa H; Yokoi H; Nanto S; Takayama M; Kitagawa K; Ikeda Y; Saito S Int J Cardiol; 2015 Mar; 182():541-8. PubMed ID: 25679803 [TBL] [Abstract][Full Text] [Related]
14. Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity. Nie XY; Li JL; Zhang Y; Xu Y; Yang XL; Fu Y; Liang GK; Lu Y; Liu J; Shi LW J Zhejiang Univ Sci B; 2017 Jan.; 18(1):37-47. PubMed ID: 28070995 [TBL] [Abstract][Full Text] [Related]
15. P2Y12 receptor gene polymorphism and the risk of resistance to clopidogrel: A meta-analysis and review of the literature. Cui G; Zhang S; Zou J; Chen Y; Chen H Adv Clin Exp Med; 2017; 26(2):343-349. PubMed ID: 28791856 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety analysis of new P2Y12 inhibitors versus clopidogrel in patients with percutaneous coronary intervention: a meta-analysis. Gan XD; Wei BZ; Fang D; Fang Q; Li KY; Ding SL; Peng S; Wan J Curr Med Res Opin; 2015 Dec; 31(12):2313-23. PubMed ID: 26402735 [TBL] [Abstract][Full Text] [Related]
17. Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: A systematic review and meta-analysis. Li JL; Fu Y; Qin SB; Liang GK; Liu J; Nie XY; Chen J; Shi LW; Shao H; Lu Y Gene; 2018 May; 657():69-80. PubMed ID: 29510176 [TBL] [Abstract][Full Text] [Related]